Latest news with #hormoneTherapy
New York Times
an hour ago
- Health
- New York Times
Judge Blocks Trump Effort to End Treatment for Transgender Inmates
The U.S. Bureau of Prisons must provide transgender inmates with hormone therapy and social accommodations such as gender-appropriate clothing while a lawsuit over the issue proceeds, a federal judge ruled on Tuesday. The ruling, by Judge Royce C. Lamberth of the U.S. District Court for the District of Columbia, also certified a class-action lawsuit filed on behalf of more than 1,000 inmates who have been diagnosed with gender dysphoria. The lawsuit claims the Trump administration's policy denying gender-related treatment to prisoners violates their Eighth Amendment right to medical care and the Administrative Procedure Act, which prohibits 'arbitrary and capricious' actions by federal agencies. In his order, Judge Lamberth said it was not necessary to address the constitutional issue at this stage of the case because the plaintiffs were likely to prevail on Administrative Procedure Act grounds. Under the act, he wrote, the Bureau of Prisons 'may not arbitrarily deprive inmates of medications or other lifestyle accommodations that its own medical staff have deemed to be medically appropriate without considering the implications of that decision.' Judge Lamberth was appointed by President Ronald Reagan. The ruling temporarily blocks a policy that stemmed from an executive order, issued by President Trump the day he took office, that no federal funds be spent for medical treatments 'for the purpose of conforming an inmate's appearance to that of the opposite sex.' That order, part of a broader push to eliminate protections for transgender people in the United States, suggested that recognizing the legitimacy of gender identities that do not match a person's biological sex 'has a corrosive impact' on the 'entire American system.' One plaintiff in the suit, Alishea Kingdom, a transgender woman who had been receiving hormone therapy since 2016, was denied hormone injections under the new policy, though she later began receiving them again, according to court documents. Two other plaintiffs, both transgender men, were told that their hormone therapies would not be renewed. Each was denied access to undergarments or hygiene products that corresponded with their gender identity. About 600 inmates with gender dysphoria are receiving hormone treatments, according to the Bureau of Prisons. The judge's order does not require the bureau to provide gender-related surgeries. The number of inmates requesting such operations is minuscule, and only two such surgeries are known to have been performed on inmates. Gender dysphoria can 'produce severe side effects ranging from depression and anxiety to suicidal ideation and self-harm if inadequately treated,' the judge wrote, adding that the Bureau of Prisons 'does not dispute this medical reality.' He wrote that it was not necessary to take into account debates over the efficacy of hormone therapies in his decision to issue a preliminary injunction against the policy. 'To conclude that the defendants have failed to meet the procedural strictures of the APA,' Judge Lamberth wrote, referring to the Administrative Procedure Act, 'is not to take any position on the underlying merits of the BOP's substantive policy decisions or the goals motivating the Executive Order.'
Daily Mail
5 days ago
- Health
- Daily Mail
AI test could help to cut the risk of dying from prostate cancer by half, study suggests
A revolutionary AI test can help slash the risk of dying from prostate cancer by up to half, a breakthrough study suggests. From examining images of tumours it was able to identify patients who could benefit from a 'game-changer' drug by picking out features invisible to the human eye. Around one in four men with 'high-risk' prostate cancer were found to have a particular biomarker that made them more receptive to the treatment. Among those with the biomarker, taking the drug abiraterone alongside standard hormone therapy cut the risk of death after five years from 17 per cent to 9 per cent – a reduction of 47 per cent. Men without the biomarker saw their risk of death drop from 7 per cent to 4 per cent – which is not thought to be statistically or clinically significant. Abiraterone, which costs just £77 for a month's supply since the patent expired, works by inhibiting the production of testosterone in all tissues throughout the body, including in the tumour. Researchers say NHS England should now make the drug available to the 2,100 men a year who could benefit, while sparing others a treatment that comes with additional side-effects. It is approved for use on the NHS in England for patients with advanced prostate cancer that has come back and spread to other parts of the body, but not for the 8,400 men a year with newly diagnosed high-risk prostate cancer that has not spread. Experts say because fewer men than previously thought will need the drug, NHS England should review the decision not to fund the treatment for those who could benefit earlier. It has been more widely available to men in Scotland and Wales for two years. Scientists from the Institute of Cancer Research (ICR), in London, and University College London examined data from more than 1,000 men whose tumours were at high risk of spreading. The findings, based on a test developed by Artera Inc, will be presented at the American Society of Clinical Oncology Annual Meeting in Chicago. The Mail has campaigned for years to improve the diagnosis and treatment of prostate cancer in a bid to prevent needless deaths. Professor Nick James, who co-led the research at the ICR, said: 'I truly hope this new research – showing precisely who needs the drug to live well for longer – will lead to NHS England reviewing their decision to fund abiraterone for high-risk prostate cancer that has not spread.' An NHS spokesman said: 'Abiraterone continues to be routinely funded by the NHS in England for several forms of advanced prostate cancer in line with clinical guidance, and we are keeping this position under close review.' Meanwhile, lung cancer patients will be offered a new blood test to speed up access to targeted treatments and avoid unnecessary biopsies. The 'liquid biopsy' looks for tiny fragments of tumour DNA and detects mutations. About 15,000 patients a year will benefit, NHS England says.
CBC
6 days ago
- Health
- CBC
Canadian Medical Association takes Alberta to court over Bill 26
A law that prohibits doctors from using puberty blockers and hormone therapy on youth under the age of 16 is facing another legal challenge.
Fox News
6 days ago
- Health
- Fox News
Planned Parenthood using 'loophole' to get minors gender transitions without parents' OK: watchdog
FIRST ON FOX: The conservative watchdog group American Principles Project is sounding an alarm over what the group is describing as a "massive loophole" being utilized by Planned Parenthood to give transgender hormone therapy to minors. In a wide-ranging report chronicling how Planned Parenthood is propping up the trans agenda, the American Principles Project accused the group and its affiliates across the country of manipulating the definition of contraception in order to provide transgender hormone therapy to minors without parental consent. "Using contraception as a 'gender-affirming' treatment is a massive loophole," the report stated. "Most states allow minors to consent to these contraceptives on their own, and many states allow minors to do so without even notifying parents." Some blue states, like Washington, Oregon and Minnesota, have laws permitting minors to obtain puberty blockers, or cross-sex hormones, for the purpose of transitioning genders, without parental consent. However, most states do require parental consent in order for minors to access these drugs, while others take an even stricter approach of banning the medications for minors outright, regardless of whether their parents approve or not. The American Principles Project points to a "Gender Affirming Care Patient Guide" from Planned Parenthood's Mar Monte chapter, the national organization's largest affiliate serving parts of central California and northern Nevada. In both states, parental consent is required for minors to access any type of medical intervention aimed at aiding a minor's gender transition, but it does permit minors to obtain various forms of contraception, such as birth control, without it. "People 15 and younger who have periods can come to us for birth control options to stop periods," the patient guide on "gender-affirming care" states. It then notes in the following sentence: "Parent/guardian consent is not required to get birth control." A 2022 case study from Seattle Children's Hospital, which has come under scrutiny for providing transgender medical care to minors, highlights the case of a 14-year-old biological female who was diagnosed with gender dysphoria and was "very distressed by bleeding cycles" that the patient began experiencing at age 12. Despite the minor patient's gender dysphoria, the child did not want to fully transition into a male. Rather, according to the case study, the female patient was identified as "non-binary" and expressed that she did not want to be subject to the effects of testosterone, such as a deeper voice and facial hair. As a result, the child was given hormonal-based birth control to stop her periods, which the case study said resulted in better mental health for the patient and opened them up to pursuing top surgery in the future. In addition to blocking periods, certain types of birth control can also suppress testosterone production, according to the Endocrine Society. This makes contraception a viable route for gender-dysphoric biological females who may not want to experience the impacts of testosterone but want to blunt their female-sex maturation, as described in the above case study. It's also a viable mechanism for biological males who want to block their body's natural testosterone production, according to the Endocrine Society. "While patients under 18 cannot receive hormone therapy, they may have a consultation with a provider to understand treatment options and to receive medications to stop their periods (if desired)," Planned Parenthood of the Pacific Southwest states on its "Gender Affirming Care" web page. The explanation also appears on a FAQ page under the website's "About Us" section. "The fact that Planned Parenthood is actively finding and exploiting legal loopholes to begin transitioning minors behind their parent's backs is downright disgusting," Terry Schilling, President of the American Principles Project told Fox News Digital. "There is nothing this organization will not do to make a quick buck at the expense of our children and families." According to the American Principles Project's report, around 80 percent of Planned Parenthood clinics offer some form of "gender-affirming care," which the group says has outpaced abortion services. The report goes into other extensive details about how Planned Parenthood has prioritized sex-change procedures for young people, which Schilling remarked "isn't healthcare" but rather "an ideological crusade that undermines families and exploits vulnerable youth." "Planned Parenthood's recent shift to becoming a leading provider of so-called 'gender-affirming care' exposes their radical agenda to reshape society, starting with our unborn children and now targeting the next generation with dangerous, life-altering medical procedures," Schilling said. "Our report reveals that Planned Parenthood now prioritizes irreversible transgender treatments—often without parental consent—OVER their other services, with an estimated 120,000 transgender medical visits annually and growing," he continued. Their materials, from activity books promoting gender ideology to chatbots targeting kids as young as 13, are designed to sexualize and indoctrinate the next generation." In a statement to Fox News Digital, Planned Parenthood of the Pacific Southwest's President and CEO, Jenny Black, insisted that its health centers "operate under the highest medical standards," and said that any accusation it is violating state law "is completely false." "We strongly denounce the dangerous spread of disinformation about life-saving gender-affirming healthcare that is fueled by rampant transphobia," Black said. "We will continue to provide safe and legal health care to those who rely on us for access to quality and compassionate care." Planned Parenthood's Mar Monte chapter did not respond to Fox News Digital's request for comment.
Associated Press
27-05-2025
- Business
- Associated Press
Deborah Wilson MD & Associates Ranked #2 for Hormone Therapy Facilities by Ranking Arizona
'We are honored to be recognized as one of the top hormone therapy facilities in Arizona.'— Deborah Wilson, MD SCOTTSDALE, AZ, UNITED STATES, May 27, 2025 / / -- Deborah Wilson MD & Associates, a premier women's health and wellness clinic in Scottsdale, is proud to announce its recognition as the #2 ranked hormone therapy facility in Arizona by Ranking Arizona, the state's definitive guide to the top businesses across various industries. Known for their commitment to providing innovative and personalized care, Deborah Wilson MD & Associates offers cutting-edge hormone solutions to help women achieve hormonal balance, vitality, and overall wellness. The clinic specializes in advanced treatments such as Bioidentical Hormone Replacement Therapy (BHRT) and Hormone Pellet Therapy, empowering women to regain control of their health and rediscover their best selves. 'We are honored to be recognized as one of the top hormone therapy facilities in Arizona,' said Dr. Deborah Wilson, founder and lead physician at Deborah Wilson MD & Associates. 'This recognition reflects our team's dedication to offering personalized care and utilizing the most advanced treatments to improve the lives of our patients. Our mission is to support women at every stage of life with the most effective, natural, and sustainable solutions for hormone balance.' Deborah Wilson MD & Associates takes pride in offering tailored treatment plans designed to meet the unique needs of each patient. Whether addressing menopause, perimenopause, menstrual dysfunction, or polycystic ovary syndrome (PCOS), the clinic provides customized bioidentical hormone treatments, including the revolutionary hormone pellet therapy, which offers patients consistent, long-term hormone relief without the need for daily management. In addition to hormone therapy, Deborah Wilson MD & Associates offers a variety of gynecological services, including small gynecological procedures and intimate wellness care. The clinic provides treatments focused on women's reproductive health and intimate well-being, helping women address concerns such as vaginal dryness, pelvic discomfort, and urinary incontinence. They have an in-house ultrasound team to perform pelvic ultrasounds as well as an in-house lab to perform blood draws so you never have to worry about scheduling an off-site appointment. By offering a range of personalized treatments in a compassionate environment, Deborah Wilson MD & Associates ensures that women receive the comprehensive care they need for both their physical and intimate health. With a focus on patient-centered care, the clinic ensures that each individual receives the attention, education, and support they need to navigate their health journey with confidence. The clinic's approach is centered on building strong relationships with patients, empowering them with knowledge and the resources to achieve optimal health. The Ranking Arizona recognition highlights the clinic's continued commitment to excellence, with patients praising the clinic for its compassionate care, professionalism, and the exceptional results they experience. For more information or to schedule a consultation, visit Deborah Wilson MD & Associates or call (480) 860-4791. About Deborah Wilson MD & Associates Located in Scottsdale, AZ, Deborah Wilson MD & Associates specializes in hormone therapy, offering innovative treatments such as Bioidentical Hormone Replacement Therapy and Hormone Pellet Therapy. The clinic's team is dedicated to empowering women by providing personalized care and utilizing the latest advancements in hormone solutions to improve overall health, vitality, and wellness. In addition, the clinic offers gynecological services, including small procedures and intimate wellness care. Deborah Wilson MD & Associates is committed to helping women achieve optimal health at every stage of life. Deborah Wilson, MD Deborah Wilson MD & Associates +1 480-860-4791 email us here Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
